Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.6795 per EA under NDC 62332041310. Its NADAC has been published 362 times since Oct 30, 2019.
FDA first approved this application on Jun 24, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332041310
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA211823FDA Approved
6/24/2019
TE Code
AB
On Market Since
6/25/2019
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 362 times since Oct 30, 2019, and over the history we have for it it has declined 88.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6795 per EA |
|---|---|
| All-time high | $5.6422 (Nov 13, 2019) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6282 |
| Median price | $1.3034 |
| Average price | $1.7960 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 362 |
| Tracking since | Oct 30, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OSELTAMIVIR market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OSELTAMIVIR market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Neuraminidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.6795 per EA (NDC 62332041310), effective Sep 30, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 88.0%. It has been tracked across 362 weekly CMS publications since Oct 30, 2019.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Oct 30, 2019, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $5.6422 (Nov 13, 2019), with a median of $1.3034 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 62332041310) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.